- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT05983185
Terapia de Adaptação de Prisma (PAT) para Reabilitação de Acidente Vascular Encefálico Direito
Prism Adaptation Treatment (PAT) para reabilitação de AVC do lado direito do cérebro
After a right brain stroke, >50% of Veterans experience problems with dressing, eating, self-care or steering their wheelchairs because their ability to move, orient, and respond toward the left side is limited: spatial neglect. Spatial neglect prevents them from functioning independently, and their needs in the hospital and at home are greatly increased. An effective treatment for spatial neglect is 10 days of visuomotor training while wearing optical prisms (PAT), however many clinicians [fail to diagnose spatial neglect and use this approach. In this study, the investigators will develop a brain scanning test that could objectively identify the Veterans with spatial neglect after stroke who are the best candidates to receive PAT and recover their ability to function. When the research is complete, the investigators expect that brain scans done in the hospital can guide the team to refer Veterans to PAT rehabilitation: improving daily life function] and quality of life.
Visão geral do estudo
Status
Intervenção / Tratamento
Descrição detalhada
Project Summary/Abstract The application addresses the formidable treatment gap for cognitive rehabilitation of spatial neglect (SN), defined as asymmetric orienting, perception, and responding to left space after right brain stroke, causing functional disability. Although Veterans with SN are half as likely to return home, have one-third the community mobility, require 3x as much caregiver supervision, and have longer hospitalizations, increased fall risk and increased rehospitalization compared with similar right brain stroke survivors, a personalized approach to SN rehabilitation is not available in Veteran-specific systems of care. The investigators discovered that frontal lobe damage and "Aiming" SN both predict optimal recovery of functional independence after prism adaptation treatment (PAT). These findings argue for the development of an [objective, biomarker-based process to identify patients who should be administered PAT. The algorithm will be developed by identifying specific neurobiological features predictive of PAT treatment response. Thus, the investigators expect this research will deliver a critical missing element to rehabilitation, eliminating clinician uncertainty about SN diagnosis and appropriateness of PAT, and allowing a more personalized health care approach to SN rehabilitation. The team of researchers at three high-performing VA medical centers, distinguished in cognitive neurology analysis of brain imaging predictors, and stroke rehabilitation, from both advanced and clinical data, will develop the first biological parameter that can be used to assign SN rehabilitation. In 180 Veterans (120 with SN, 60 without), the investigators will define and validate brain imaging biomarkers that predict the presence of Aiming SN (Aim 1), a strong predictor of functional recovery after receiving PAT. The expectation that disconnection of frontal regions with subcortical and parietal regions will predict Aiming SN. The investigators will also examine the correlation between the brain imaging biomarkers predicting Aiming SN and improvements in daily life function after PAT (Aim 2).] Then, the investigators will determine if adding behavioral predictors to biomarker predictors (Aim 3) accounts for additional variance in the trajectory of functional recovery. The overall impact of the investigators' work will be to establish the utility of a validated biomarker that routinely identifies Veterans with SN after stroke who are the best candidates for PAT. Armed with a biomarker-based algorithm, the investigators can then carry out a large-scale PAT clinical trial, and personalized SN care. This care pathway could reduce reliance on specialized SN assessment, [coordinate VA and community systems providing Veteran stroke care,] and improve stroke care efficiency, to enhance outcomes and quality of life after stroke for thousands of Veterans.
Tipo de estudo
Inscrição (Estimado)
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
- Nome: Anna M Barrett, MD
- E-mail: Anna.Barrett2@va.gov
Estude backup de contato
- Nome: Akila Sanjay, BA
- Número de telefone: (508) 856-0104
- E-mail: akila.sanjay@va.gov
Locais de estudo
-
-
Connecticut
-
West Haven, Connecticut, Estados Unidos, 06516-2770
- Recrutamento
- VA Connecticut Healthcare System West Haven Campus, West Haven, CT
-
Contato:
- Sharon Bottomley, DNP
- Número de telefone: 203-932-5711
- E-mail: sharon.bottomley@va.gov
-
Contato:
- Nishant Mishra, MD
- Número de telefone: 6504408349
- E-mail: nishant.mishra@va.gov
-
-
Georgia
-
Decatur, Georgia, Estados Unidos, 30033-4004
- Recrutamento
- Atlanta VA Medical and Rehab Center, Decatur, GA
-
Contato:
- Michael Dattilo, MD
- Número de telefone: 20660 4043216111
- E-mail: michael.datillo@va.gov
-
Contato:
- Mychaela Eatmon
- Número de telefone: 404-725-3256
- E-mail: mychaela.eatmon@va.gov
-
-
Massachusetts
-
Leeds, Massachusetts, Estados Unidos, 01053-9764
- Recrutamento
- VA Central Western Massachusetts Healthcare System, Leeds, MA
-
Investigador principal:
- Anna M. Barrett, MD
-
Contato:
- Anna M Barrett, MD
- E-mail: Anna.Barrett2@va.gov
-
Contato:
- Emily Muller, BA
- Número de telefone: 508-254-7217
- E-mail: emily.muller@umassmed.edu
-
-
Ohio
-
Cleveland, Ohio, Estados Unidos, 44106-1702
- Recrutamento
- Louis Stokes VA Medical Center, Cleveland, OH
-
Contato:
- Jessica McCabe, PT
- Número de telefone: 8203830 216-791-3800
- E-mail: jessica.mccabe@va.gov
-
Contato:
- Svetlana Pundik
- Número de telefone: 63732 2167913800
- E-mail: svetlana.pundik@va.gov
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Has had a first right brain stroke >18 years of age
- 1-4 months post-diagnosis of right brain stroke
- Can sit up, see out of both eyes and point to objects (>20/50 vision in both eyes)
- Can give informed consent to participate
Exclusion Criteria:
- Has been diagnosed with other chronic, disabling neurological disorder (e.g. multiple sclerosis, Alzheimer Disease)
- Has had a clinical left brain stroke or has neuroimaging evidence of prior stroke(s) including the presence of more than two lacunes with diameter greater than 15 mm.
- Cannot sit up to be tested and receive PAT
- Has <20/50 vision when viewing with both eyes
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Diagnóstico
- Alocação: Não randomizado
- Modelo Intervencional: Atribuição de grupo único
- Mascaramento: Solteiro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Comparador Ativo: Prism adaptation Therapy
People with spatial neglect will receive this effective treatment to reduce symptoms, which the investigators' previous work indicated may be particularly effective for Aiming SN symptoms. |
The investigators' research and clinical group is the US leader in implementing this intervention for spatial neglect and have brought it to more than 50 clinical centers, hospitals, and treatment organizations.
Outros nomes:
|
|
Sem intervenção: No spatial neglect
People without spatial neglect symptoms will not receive an intervention for spatial neglect. |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Spatial neglect (SN) type (Aiming SN versus Where SN)
Prazo: baseline
|
This variable is assignment to category defining spatial neglect. This is based on a data collection with computerized line bisection, which generates a profile score. Veterans whose computerized line bisection profile score indicates that they have spatial neglect that primarily affects movement, intention and action have Aiming SN; these Veterans responded best to prism adaptation therapy (PAT) in prior research. Alternately, Veterans may have a profile score consistent with Where SN, affecting perception and action. |
baseline
|
|
Functional independence Measure (FIM) improvement trajectory
Prazo: 5 weeks after enrollment
|
This outcome variable measures how well Veterans can carry out their daily life self-care activities independently on a validated measure, the Functional Independence Measure (FIM). |
5 weeks after enrollment
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
SN severity, as assessed by the Behavioral Inattention Test-conventional subtest (BIT-c)
Prazo: 5 weeks after enrollment
|
This variable examines the severity of spatial neglect as measured by functionally-valid assessment, the Behavioral Inattention Test-conventional subtest (BIT-c; max value 146, min value 0, lower is abnormal). Functionally-valid spatial neglect assessments predict independence for activities of daily living, and care needs. |
5 weeks after enrollment
|
|
SN severity, as assessed by the Catherine Bergego Scale (CBS)
Prazo: 5 weeks after enrollment
|
This variable (max value 30, min value 0, higher is abnormal) examines the severity of spatial neglect as measured by a functionally-valid assessment, the CBS. Functionally-valid spatial neglect assessments predict independence for activities of daily living, and care needs. |
5 weeks after enrollment
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Anna M. Barrett, MD, VA Central Western Massachusetts Healthcare System, Leeds, MA
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Outros números de identificação do estudo
- C3662-R
- 1I01RX003662-01A1 (Concessão/Contrato do NIH dos EUA)
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
produto fabricado e exportado dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .